Form 4 for ELVN Enliven Therapeutics, Inc.
Accepted 2024-04-12 00:00:00 ET · period of report 2024-04-10 · accession 0001415889-24-010777 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2024-04-12 | 2024-04-10+ | ELVN | Ballal Rahul D. | Dir | M - OptEx | $13.08 | +67.0K | 75.7K | +767% | +$876.6K |
| DM | 2024-04-12 | 2024-04-10+ | ELVN | Ballal Rahul D. | Dir | S - Sale+OE | $23.36 | -67.0K | 45.4K | -60% | -$1.57M |
| DM | 2024-04-12 | 2024-04-10+ | ELVN | Ballal Rahul D. | Dir | M - OptEx | $0.00 | -67.0K | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-04-11 | M | A | 48,820 | $12.60 | 71,161 | D | — | — | |
| 2 | Common | Common Stock | 2024-04-10 | M | A | 13,600 | $12.60 | 35,941 | D | — | — | |
| 3 | Common | Common Stock | 2024-04-10 | S | D | 13,600 | $21.01 | 22,341 | D | — | — | (F2) This transaction was executed in multiple trades at prices ranging from $21.00 to $21.16. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price. |
| 4 | Common | Common Stock | 2024-04-11 | S | D | 3,068 | $25.21 | 22,341 | D | — | — | (F5) This transaction was executed in multiple trades at prices ranging from $25.02 to $25.485. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price. |
| 5 | Common | Common Stock | 2024-04-11 | S | D | 20,032 | $25.00 | 25,409 | D | — | — | (F4) This transaction was executed in multiple trades at prices ranging from $24.015 to $25.01. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price. |
| 6 | Common | Common Stock | 2024-04-11 | S | D | 30,300 | $23.14 | 45,441 | D | — | — | (F3) This transaction was executed in multiple trades at prices ranging from $23.00 to $23.94. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price. |
| 7 | Common | Common Stock | 2024-04-11 | M | A | 4,580 | $19.68 | 75,741 | D | — | — | |
| 8 | Derivative | Stock Option (right to buy) | 2024-04-10 | M | D | 13,600 | $0.00 | 48,820 | D | $12.60 · — to 2028-10-19 | 13,600 Common Stock | (F6) All of the shares subject to this option are fully vested and exercisable as of the date hereof. |
| 9 | Derivative | Stock Option (right to buy) | 2024-04-11 | M | D | 4,580 | $0.00 | 75,742 | D | $19.68 · — to 2029-05-16 | 4,580 Common Stock | (F6) All of the shares subject to this option are fully vested and exercisable as of the date hereof. |
| 10 | Derivative | Stock Option (right to buy) | 2024-04-11 | M | D | 48,820 | $0.00 | 0 | D | $12.60 · — to 2028-10-19 | 48,820 Common Stock | (F6) All of the shares subject to this option are fully vested and exercisable as of the date hereof. |